Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma

Summary. Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by John Cunningham virus (JCV). We present a case report of patient with non-Hodgkin follicular lymphoma, who developed PML after hematopoietic stem cell tra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Trociukas, I., Zirnis, A.E., Beļajeva, L., Rivkina, A., Lejniece, S.
Format: Artikel
Sprache:Englisch
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-19
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
_version_ 1856543498430316544
author Trociukas, I.
Zirnis, A.E.
Beļajeva, L.
Rivkina, A.
Lejniece, S.
author_facet Trociukas, I.
Zirnis, A.E.
Beļajeva, L.
Rivkina, A.
Lejniece, S.
author_sort Trociukas, I.
baseUrl_str
collection OJS
datestamp_date 2023-10-11T16:43:26Z
description Summary. Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by John Cunningham virus (JCV). We present a case report of patient with non-Hodgkin follicular lymphoma, who developed PML after hematopoietic stem cell transplantation and rituximab-bendamustine therapy. JCV DNA was proven both in peripheral blood and cerebrospinal fluid. Patient with 4 years history of follicular lymphoma presented with progressing weakness in the right arm and leg and postural instability. Magnetic resonance imaging scans showed bilateral hyperintense lesions in the cerebellum and centrum semiovale consistent with findings in PML. JCV DNA was detected in patient peripheral blood and cerebrospinal fluid by real time polymerase chain reaction assay in CERBA laboratory (France). Human herpes simplex 6 and 7 DNA were also detected in peripheral blood by PCR. Patients condition rapidly deteriorated with exitus letalis after 3 months and 2 weeks from onset of symptoms. This case draws attention to risk for developing PML in patients with long-standing hematological malignancies.
first_indexed 2025-07-17T12:16:13Z
format Article
id oai:ojs2.ex.aqua-time.com.ua:article-182
institution Experimental Oncology
language English
last_indexed 2025-07-17T12:16:13Z
publishDate 2023
publisher PH Akademperiodyka
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-1822023-10-11T16:43:26Z Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma Trociukas, I. Zirnis, A.E. Beļajeva, L. Rivkina, A. Lejniece, S. follicular lymphoma, hematopoietic stem cell transplantation, JC polyomavirus, progressive multifocal leukoencephalopathy, rituximab-bendamustine follicular lymphoma, hematopoietic stem cell transplantation, JC polyomavirus, progressive multifocal leukoencephalopathy, rituximab-bendamustine Summary. Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by John Cunningham virus (JCV). We present a case report of patient with non-Hodgkin follicular lymphoma, who developed PML after hematopoietic stem cell transplantation and rituximab-bendamustine therapy. JCV DNA was proven both in peripheral blood and cerebrospinal fluid. Patient with 4 years history of follicular lymphoma presented with progressing weakness in the right arm and leg and postural instability. Magnetic resonance imaging scans showed bilateral hyperintense lesions in the cerebellum and centrum semiovale consistent with findings in PML. JCV DNA was detected in patient peripheral blood and cerebrospinal fluid by real time polymerase chain reaction assay in CERBA laboratory (France). Human herpes simplex 6 and 7 DNA were also detected in peripheral blood by PCR. Patients condition rapidly deteriorated with exitus letalis after 3 months and 2 weeks from onset of symptoms. This case draws attention to risk for developing PML in patients with long-standing hematological malignancies. Summary. Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by John Cunningham virus (JCV). We present a case report of patient with non-Hodgkin follicular lymphoma, who developed PML after hematopoietic stem cell transplantation and rituximab-bendamustine therapy. JCV DNA was proven both in peripheral blood and cerebrospinal fluid. Patient with 4 years history of follicular lymphoma presented with progressing weakness in the right arm and leg and postural instability. Magnetic resonance imaging scans showed bilateral hyperintense lesions in the cerebellum and centrum semiovale consistent with findings in PML. JCV DNA was detected in patient peripheral blood and cerebrospinal fluid by real time polymerase chain reaction assay in CERBA laboratory (France). Human herpes simplex 6 and 7 DNA were also detected in peripheral blood by PCR. Patients condition rapidly deteriorated with exitus letalis after 3 months and 2 weeks from onset of symptoms. This case draws attention to risk for developing PML in patients with long-standing hematological malignancies. PH Akademperiodyka 2023-05-31 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-19 10.32471/exp-oncology.2312-8852.vol-42-no-3.15198 Experimental Oncology; Vol. 42 No. 3 (2020): Experimental Oncology; 238-241 Експериментальна онкологія; Том 42 № 3 (2020): Експериментальна онкологія; 238-241 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-3 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-19/2020-3-19 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle follicular lymphoma
hematopoietic stem cell transplantation
JC polyomavirus
progressive multifocal leukoencephalopathy
rituximab-bendamustine
Trociukas, I.
Zirnis, A.E.
Beļajeva, L.
Rivkina, A.
Lejniece, S.
Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_alt Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_full Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_fullStr Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_full_unstemmed Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_short Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma
title_sort progressive multifocal encephalopathy in a patient with non-hodgkin follicular lymphoma
topic follicular lymphoma
hematopoietic stem cell transplantation
JC polyomavirus
progressive multifocal leukoencephalopathy
rituximab-bendamustine
topic_facet follicular lymphoma
hematopoietic stem cell transplantation
JC polyomavirus
progressive multifocal leukoencephalopathy
rituximab-bendamustine
follicular lymphoma
hematopoietic stem cell transplantation
JC polyomavirus
progressive multifocal leukoencephalopathy
rituximab-bendamustine
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-19
work_keys_str_mv AT trociukasi progressivemultifocalencephalopathyinapatientwithnonhodgkinfollicularlymphoma
AT zirnisae progressivemultifocalencephalopathyinapatientwithnonhodgkinfollicularlymphoma
AT belajeval progressivemultifocalencephalopathyinapatientwithnonhodgkinfollicularlymphoma
AT rivkinaa progressivemultifocalencephalopathyinapatientwithnonhodgkinfollicularlymphoma
AT lejnieces progressivemultifocalencephalopathyinapatientwithnonhodgkinfollicularlymphoma